SCHEMBL3360465

SCHEMBL3360465

OC(Nc1ccc(Br)cn1)c1c(-c2ccc(F)c(Cl)c2)nc2ccc(Br)cn12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.41
NR1H4 Q96RI1 1/20 0.38
MEN1 O00255 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 2/20 0.36
KMT2A Q03164 2/20 0.36
TP53 P04637 1/20 0.36
ALOX15 P16050 1/20 0.36
PPARG P37231 1/20 0.36
NCOA2 Q15596 1/20 0.36
NCOA1 Q15788 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
MAPK14 Q16539 1/20 0.35
TGFBR1 P36897 10/20 0.35
TGFBR2 P37173 2/20 0.35
GFER P55789 1/20 0.34
HIF1A Q16665 1/20 0.34
GAA P10253 1/20 0.34
PRNP P04156 1/20 0.33
SLC2A1 P11166 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3392155 0.91 TRPA1 (0.39) TRPA1MEN1MAPTHPGDKMT2A
SCHEMBL3359454 0.87 NR1H4 (0.39) TRPA1NR1H4MEN1MAPTKMT2A
SCHEMBL3395127 0.86 AHR (0.37) TRPA1MAPTTP53MAPK14TGFBR1
SCHEMBL3360406 0.83 MEN1 (0.41) TRPA1MEN1MAPTHPGDKMT2A
SCHEMBL14632043 0.81 FDPS (0.33) TRPA1MEN1MAPTHPGDKMT2A
SCHEMBL15879713 0.79 SLC2A1 (0.46) TRPA1NR1H4MAPTTP53GFER
SCHEMBL14632083 0.76 GABRD (0.38) MEN1MAPTKMT2ATP53GAA
SCHEMBL3391218 0.75 MAPT (0.45) TRPA1MEN1MAPTKMT2ATP53
SCHEMBL3363076 0.72 MAPT (0.48) NR1H4MEN1MAPTHPGDKMT2A
SCHEMBL1691759 0.72 SLC2A1 (0.48) TRPA1NR1H4MEN1KMT2ATGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS BIOVITRUM AB (PUBL) (SE) 2015-08-27 US disclosed
US-20140206662-A1 Imidazopyridine Compounds PROXIMAGEN LTD. (GB) 2014-07-24 US disclosed
EP-2376490-B1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD (GB) 2013-01-23 EP disclosed
WO-2010064020-A1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD. (GB) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS SSB, MIF, IDO1 TRPA1 162/4885NR1H4 3133/4885MEN1 3221/4885
US-20140206662-A1 Imidazopyridine Compounds SSB, NFKBIA, TPMT TRPA1 159/4885NR1H4 2743/4885MEN1 2908/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.